It has been demonstrated that TLR4 signaling may promote NAFLD progression, and NASH is characterized by an increased sensitivity to bacterial LPS, a TLR4 ligand (Szabo et al., 2005). The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.